Peer Review reports
From: HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme
| Original Submission | ||
|---|---|---|
| 8 Sep 2021 | Submitted | Original manuscript |
| 11 Oct 2021 | Reviewed | Reviewer Report |
| 28 Nov 2021 | Reviewed | Reviewer Report - Carl-friedrich Classen |
| 25 Jan 2022 | Author responded | Author comments - Hardev Pandha |
| Resubmission - Version 2 | ||
| 25 Jan 2022 | Submitted | Manuscript version 2 |
| 22 Feb 2022 | Author responded | Author comments - Hardev Pandha |
| Resubmission - Version 3 | ||
| 22 Feb 2022 | Submitted | Manuscript version 3 |
| 7 Mar 2022 | Author responded | Author comments - Hardev Pandha |
| Resubmission - Version 4 | ||
| 7 Mar 2022 | Submitted | Manuscript version 4 |
| 8 Mar 2022 | Author responded | Author comments - Hardev Pandha |
| Resubmission - Version 5 | ||
| 8 Mar 2022 | Submitted | Manuscript version 5 |
| 18 Mar 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 21 Mar 2022 | Editorially accepted | |
| 13 Apr 2022 | Article published | 10.1186/s12885-022-09466-8 |
You can find further information about peer review here.